{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:49:31Z","timestamp":1784177371066,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2019,12]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n HIV infected patients receiving antiretroviral therapy (ART) have extensive musculoskeletal system involvement. Arthralgia and myalgia are the most common forms. Fibromyalgia Syndrome (FMS) is a chronic pain syndrome of the musculoskeletal system characterized by diffuse pain including arthralgia and myalgia. These overlapping symptoms are suggested the relationship between HIV and FMS. The primary purpose of this study was to determine the prevalence of FMS in HIV\/AIDS patients. The secondary objective was to investigate the effects of FMS on functional status, depression, fatigue, sleep pattern and quality of life.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A total of 225 HIV infected patients who were receiving ART were included in this cross-sectional prospective study. The demographic data of the participants, CD4 T-lymphocyte count (cells\/mm3<\/jats:sup>), viral load (>\u200940 copy\/ml), and ART regimens were recorded. FMS diagnosis was based on 2016 revision of diagnostic criteria. All patients completed the following questionnaires:\u00a0Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS), and SF-36 scale.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n FMS was found in 20% of the HIV infected patients (n\u2009=\u200945). The mean duration of disease was 4.74\u2009\u00b1\u20094.42\u00a0years; it was significantly longer in patients with FMS (p\u2009=\u20090.007). The median CD4 T-lymphocyte count was found to be 616.00\u2009\u00b1\u2009303.91 cells\/mm3<\/jats:sup>, and it was significantly higher in patients without FMS (p\u2009=\u20090.06). No statistically significant difference was found between the two groups according to the drug regimens used. A statistically significant difference was found in FIQ, BDI, PSQI, FSS and all subgroups of the SF-36 scale between the patients with and without FMS (p\u2009=\u20090.001).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n A slightly higher frequency of FMS was determined in HIV infected patients receiving ART compared to previous studies. It was shown that presence of FMS negatively affected the function, depression, fatigue, sleep, and quality of life. Detection of FMS may decrease depression, fatigue, and sleep disorders and increase the quality of life in HIV infected patients. FMS should be distinguished correctly for an accurate treatment management of HIV and for increasing ART compliance.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12941-019-0330-0","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T16:05:21Z","timestamp":1572537921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The effect of concomitant fibromyalgia in HIV infected patients receiving antiretroviral therapy: a prospective cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Umit Secil","family":"Demirdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neriman","family":"Bilir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna","family":"Demirdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"330_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2017.1306759","author":"E Briones-Vozmediano","year":"2018","unstructured":"Briones-Vozmediano E, \u00d6hman A, Goicolea I, Vives-Cases C. \u201cThe\u00a0complaining\u00a0women\u201d: health professionals\u2019 perceptions on patients with fibromyalgia in\u00a0Spain. Disabil Rehabil. 2018. \n https:\/\/doi.org\/10.1080\/09638288.2017.1306759\n \n .","journal-title":"Disabil Rehabil"},{"key":"330_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1252","author":"MA Fitzcharles","year":"2018","unstructured":"Fitzcharles MA, Perrot S, H\u00e4user W. Comorbid\u00a0fibromyalgia: a\u00a0qualitative\u00a0review\u00a0of\u00a0prevalence\u00a0and\u00a0importance. Eur J Pain. 2018. \n https:\/\/doi.org\/10.1002\/ejp.1252\n \n .","journal-title":"Eur J Pain"},{"key":"330_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/path.4449","author":"S Lucas","year":"2015","unstructured":"Lucas S, Nelson AM. HIV\u00a0and the\u00a0spectrum\u00a0of\u00a0human\u00a0disease. J Pathol. 2015. \n https:\/\/doi.org\/10.1002\/path.4449\n \n .","journal-title":"J Pathol."},{"key":"330_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61809-7","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The\u00a0end\u00a0of\u00a0AIDS:\u00a0HIV infection\u00a0as a\u00a0chronic disease. Lancet. 2013. \n https:\/\/doi.org\/10.1016\/S0140-6736(13)61809-7\n \n .","journal-title":"Lancet"},{"key":"330_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4089-z","author":"K Parperis","year":"2019","unstructured":"Parperis K, Abdulqader Y, Myers R, Bhattarai B, Al-Ani M. Rheumatic\u00a0diseases\u00a0in\u00a0HIV-infected\u00a0patients\u00a0in the\u00a0post-antiretroviral\u00a0therapy\u00a0era: a\u00a0tertiary\u00a0carecenter\u00a0experience. Clin Rheumatol. 2019. \n https:\/\/doi.org\/10.1007\/s10067-018-4089-z\n \n .","journal-title":"Clin Rheumatol"},{"key":"330_CR6","first-page":"24","volume":"11","author":"M Kaddu-Mukasa","year":"2011","unstructured":"Kaddu-Mukasa M, Ssekasanvu E, Ddumba E, Thomas D, Katabira ET. Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital. Afr Health Sci. 2011;11:24\u20139.","journal-title":"Afr Health Sci."},{"key":"330_CR7","first-page":"1760","volume":"34","author":"X Zhang","year":"2007","unstructured":"Zhang X, Li H, Li T, Zhang F, Han Y. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China. J Rheumatol. 2007;34:1760\u20134.","journal-title":"J Rheumatol"},{"key":"330_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2015.04.019","author":"C Fox","year":"2015","unstructured":"Fox C, Walker-Bone K. Evolving\u00a0spectrum of\u00a0HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol. 2015. \n https:\/\/doi.org\/10.1016\/j.berh.2015.04.019\n \n .","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"330_CR9","first-page":"S34","volume":"34","author":"I Dotan","year":"2016","unstructured":"Dotan I, Riesenberg K, Toledano R, Schlaeffer F, Smolyakov A, Saidel-Odes L, et al. Prevalence and characteristics of fibromyalgia among\u00a0HIV-positive patients in southern Israel. Clin Exp Rheumatol. 2016;34:S34\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"330_CR10","doi-asserted-by":"publisher","first-page":"OA3","DOI":"10.15305\/ijrci\/v5i1\/229","volume":"5","author":"S Naorem","year":"2017","unstructured":"Naorem S, Arvind G, Naorem B, Devi SB. Prevalence of rheumatic manifestations in HIV patients: a cross-sectional study from Manipur, India. IJRCI. 2017;5:OA3.","journal-title":"IJRCI."},{"key":"330_CR11","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7184.120542","author":"AK Kole","year":"2013","unstructured":"Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in\u00a0HIV\u00a0infection: experience in a tertiary referral center. Indian J Sex Transm Dis AIDS. 2013. \n https:\/\/doi.org\/10.4103\/0253-7184.120542\n \n .","journal-title":"Indian J Sex Transm Dis AIDS."},{"key":"330_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.012","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H\u00e4user W, Katz RL, et al. Revisions to the 2010\/2011\u00a0fibromyalgia\u00a0diagnostic\u00a0criteria. Semin Arthritis Rheum. 2016. \n https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.012\n \n .","journal-title":"Semin Arthritis Rheum"},{"key":"330_CR13","first-page":"154","volume":"23","author":"RM Bennett","year":"2005","unstructured":"Bennett RM. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23:154\u201362.","journal-title":"Clin Exp Rheumatol"},{"key":"330_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002960000077","volume":"20","author":"S Sarmer","year":"2000","unstructured":"Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9\u201312.","journal-title":"Rheumatol Int"},{"key":"330_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","journal-title":"Arch Gen Psychiatry"},{"key":"330_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/da.20371","volume":"25","author":"EG Kapci","year":"2008","unstructured":"Kapci EG, Uslu R, Turkcapar H, Karaoglan A. Beck Depression Inventory II: evaluation of the psychometric properties and cut-off points in a Turkish adult population. Depress Anxiety. 2008;25:104\u201310.","journal-title":"Depress Anxiety."},{"key":"330_CR17","first-page":"107","volume":"7","author":"MY Agargun","year":"1996","unstructured":"Agargun MY, Kara H, Anlar O. Pittsburgh Uyku Kalitesi Indeksi\u2019nin Gecerligi ve Guvenirligi (Turkish). Turk Psikiyatri Derg. 1996;7:107\u201311.","journal-title":"Turk Psikiyatri Derg"},{"key":"330_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"330_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1558-3","author":"A Gencay-Can","year":"2012","unstructured":"Gencay-Can A, Can SS. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol Int. 2012. \n https:\/\/doi.org\/10.1007\/s00296-010-1558-3\n \n .","journal-title":"Rheumatol Int"},{"key":"330_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121\u20133.","journal-title":"Arch Neurol"},{"key":"330_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"330_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2016.1274013","author":"JG da Silva","year":"2017","unstructured":"da Silva JG, da Rocha Morgan DA, Melo FCM, Dos Santos IK, de Azevedo KPM, de Medeiros HJ, et al. Level\u00a0of\u00a0pain\u00a0and\u00a0quality of life\u00a0of\u00a0people\u00a0living\u00a0with\u00a0HIV\/AIDS\u00a0pain\u00a0and\u00a0quality of life\u00a0in\u00a0HIV\/AIDS. AIDS Care. 2017. \n https:\/\/doi.org\/10.1080\/09540121.2016.1274013\n \n .","journal-title":"AIDS Care."},{"key":"330_CR23","first-page":"1202","volume":"17","author":"D Buskila","year":"1990","unstructured":"Buskila D, Gladman DD, Langevitz P, Urowitz S, Smythe HA. Fibromyalgia in human immunodeficiency virus infecting. J Rheumatol. 1990;17:1202\u20136.","journal-title":"J Rheumatol"},{"key":"330_CR24","first-page":"1775","volume":"88","author":"P Chiowchanwisawakit","year":"2005","unstructured":"Chiowchanwisawakit P, Koolvisoot A, Ratanasuwan W, Suwanagool S. Prevalence\u00a0of\u00a0rheumatic disease\u00a0in\u00a0HIV\u00a0infected\u00a0Thai\u00a0patients. J Med Assoc Thai. 2005;88:1775\u201381.","journal-title":"J Med Assoc Thai"},{"key":"330_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20140","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The\u00a0American\u00a0College\u00a0of\u00a0Rheumatology\u00a0preliminary\u00a0diagnostic\u00a0criteria\u00a0for\u00a0fibromyalgia\u00a0and\u00a0measurement\u00a0of\u00a0symptom\u00a0severity. Arthritis Care Res (Hoboken). 2010. \n https:\/\/doi.org\/10.1002\/acr.20140\n \n .","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"330_CR26","unstructured":"DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. \n https:\/\/aidsinfo.nih.gov\/guidelines\n \n . Accessed 13 Sept 2019."},{"key":"330_CR27","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.15.00842","author":"J Pretell-Mazzini","year":"2016","unstructured":"Pretell-Mazzini J, Subhawong T, Hernandez VH, Campo R. HIV and orthopaedics:\u00a0musculoskeletal\u00a0manifestations\u00a0and\u00a0outcomes. J Bone Joint Surg Am. 2016. \n https:\/\/doi.org\/10.2106\/JBJS.15.00842\n \n .","journal-title":"J Bone Joint Surg Am"},{"key":"330_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken132","author":"UA Walker","year":"2008","unstructured":"Walker UA, Tyndall A, Daikeler T. Rheumatic\u00a0conditions\u00a0in\u00a0human immunodeficiency virus infection. Rheumatology (Oxford). 2008. \n https:\/\/doi.org\/10.1093\/rheumatology\/ken132\n \n .","journal-title":"Rheumatology (Oxford)"},{"key":"330_CR29","doi-asserted-by":"publisher","DOI":"10.1310\/hct1306-324","author":"KM Erlandson","year":"2012","unstructured":"Erlandson KM, Allshouse AA, Jankowski CM, Duong S, Mawhinney S, Kohrt WM, et al. Comparison of\u00a0functional\u00a0status instruments in\u00a0HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials. 2012. \n https:\/\/doi.org\/10.1310\/hct1306-324\n \n .","journal-title":"HIV Clin Trials."},{"key":"330_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216787","author":"NS Van de Ven","year":"2019","unstructured":"Van de Ven NS, Ngalamika O, Martin K, Davies KA, Vera JH. Impact of musculoskeletal symptoms on physical functioning and quality of life among treated people with HIV in high and low resource settings: a case study of the UK and Zambia. PLoS ONE. 2019. \n https:\/\/doi.org\/10.1371\/journal.pone.0216787\n \n .","journal-title":"PLoS ONE"},{"key":"330_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2018.1468012","author":"BR Goodin","year":"2018","unstructured":"Goodin BR, Owens MA, White DM, Strath LJ, Gonzalez C, Rainey RL, et al. Intersectional health-related stigma in persons living with\u00a0HIV\u00a0and\u00a0chronic pain: implications for\u00a0depressive\u00a0symptoms. AIDS Care. 2018. \n https:\/\/doi.org\/10.1080\/09540121.2018.1468012\n \n .","journal-title":"AIDS Care."},{"key":"330_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001369","author":"W Scott","year":"2018","unstructured":"Scott W, Arkuter C, Kioskli K, Kemp H, Mcracken LM, Rice ASC, et al. Psychosocial factors associated with persistent pain in people with HIV: a systematic review with meta-analysis. Pain. 2018. \n https:\/\/doi.org\/10.1097\/j.pain.0000000000001369\n \n .","journal-title":"Pain"},{"key":"330_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/2325957415601502","author":"R Sandoval","year":"2015","unstructured":"Sandoval R, Gilkerson R. Management\u00a0of\u00a0sleep\u00a0quality\u00a0and\u00a0pain\u00a0in an\u00a0individual\u00a0living\u00a0with\u00a0HIV\u00a0and\u00a0hepatitis\u00a0C coinfection\u00a0using an\u00a0activity\u00a0monitor. J Int Assoc Provid AIDS Care. 2015. \n https:\/\/doi.org\/10.1177\/2325957415601502\n \n .","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"330_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0401-0","author":"C Gamaldo","year":"2013","unstructured":"Gamaldo C, Spira A, Hock R, Salas RE, McArthur JC, David PM, et al. Sleep, function and HIV: a multi-method assessment. AIDS Behav. 2013. \n https:\/\/doi.org\/10.1007\/s10461-012-0401-0\n \n .","journal-title":"AIDS Behav"},{"key":"330_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.14793","author":"A Bergamaschi","year":"2019","unstructured":"Bergamaschi A, d\u2019Arripe-Longueville F, Gray LL, Colson SS, Goujard C, Ferez S, et al. Perceived\u00a0HIV-related physical\u00a0fatigue, sociodemographic characteristics and physical activity: a cross-sectional study. J Clin Nurs. 2019. \n https:\/\/doi.org\/10.1111\/jocn.14793\n \n .","journal-title":"J Clin Nurs"},{"key":"330_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.06.010","author":"NM Robbins","year":"2013","unstructured":"Robbins NM, Chaiklang K, Supparatpinyo K. Undertreatment of\u00a0pain\u00a0in\u00a0HIV+\u2009adults in Thailand. J Pain Symptom Manage. 2013. \n https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.06.010\n \n .","journal-title":"J Pain Symptom Manage"},{"key":"330_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnr.2016.11.007","author":"CL Coleman","year":"2017","unstructured":"Coleman CL. Health related quality of life\u00a0and\u00a0depressive symptoms among seropositive African Americans. Appl Nurs Res. 2017. \n https:\/\/doi.org\/10.1016\/j.apnr.2016.11.007\n \n .","journal-title":"Appl Nurs Res"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-019-0330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-019-0330-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-019-0330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:11:29Z","timestamp":1604016689000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-019-0330-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1186\/s12941-019-0330-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by The Clinical Research Ethics Commitee of Izmir Katip Celebi University ethical committee (Year: 2018, No: 232).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given verbal consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}